JPMorgan Chase: Bank of Japan (BOJ) September Rate Hike Risk Significantly Higher, Maintaining October Baseline Forecast and Raising 2027 Rate Hikes to Three
JPMorgan Chase released a report on August 7, stating that the Japanese government's push for tax cuts and expanded fiscal support will increase pressure on the Bank of Japan (BOJ) to tighten monetary policy. The bank acknowledged a significant increase in the risk of a Bank of Japan (BOJ) rate hike in September but maintained its baseline forecast for a rate hike in October. At the same time, JPMorgan Chase raised its Bank of Japan (BOJ) rate hike forecast for 2027 from two to three, expecting the policy rate to reach 2% by the end of 2027. The report warned that domestic political pressure in Japan to slow down rate hikes could lead the Bank of Japan (BOJ) to continue lagging behind inflation, and future catch-up rate hikes might push the terminal rate above the currently predicted 2%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:华尔街见闻 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
XRP is testing the $1.50 resistance level, a key threshold that has capped its advances for roughly 230 days, with a break potentially leading to $1.80+
-
2
Seoul stocks rise 1.65% on chip gains despite Middle East tensions
-
3
Binance Stock Trading Platform Adds 25 New Stocks
-
4
Morgan Stanley’s Wilson Says US Stocks Risk 7% Drop in Near Term
-
5
US equity futures rise, led by AI stocks; oil prices fall over 2% to around $101; US Treasury yields decline; US and Chinese officials discuss AI national security "notification mechanism."
-
6
Commodities trader Trafigura plans to float its supertanker arm Volare Shipping in Oslo, marking the business's first IPO
-
7
JPMorgan CEO Dimon to Visit India This Week, Ramping Up Push for Deal Boom
-
8
Central Bank Digital Currency (CBDC) In-Depth Analysis: Global Progress and Impact
-
9
Novo Nordisk, the Danish pharmaceutical giant, saw its shares fall by 7% despite setting a $23 billion sales target for its weight-loss drug.
-
10
BiblePay (BBP) Cryptocurrency Analysis: Charitable Mission, Technical Features, and Market Status
Markets Today
Recommended Reading




